Novartis, Bayer among animal-health bidders

At least three drug companies--including Novartis and Boehringer Ingelheim--have made initial bids and remain in the race for animal health operations put on sale by Merck ($MRK) and Sanofi-Aventis ($SNY), sources tell Reuters. Report

Suggested Articles

Life sciences companies have pivoted quickly during COVID-19 - Syneos Health® is supporting more than 80 active COVID-19 projects, including vaccines.

New York's Covaxx has signed on with three South American nations to provide 140 million doses of its early-stage COVID-19 vaccine.

To get the COVID-19 vaccine out quickly, Pfizer has been running rehearsals at distribution sites, creating "growing confidence," U.S. officials said.